Cibinqo (abrocitinib)

$1,571.74$1,958.53

Cibinqo (abrocitinib) is a prescription medicine used to treat adults and adolescents 12 years of age and older with moderate-to-severe atopic dermatitis, also known as atopic eczema.

DISEASE INDICATIONS

Atopic Dermatitis

MANUFACTURER

Pfizer Limited

USAGE

Oral

MEDICINE APPROVED BY

  • European Medical Agency (EMA)

  • Food and Drug Administration (FDA)

  • Pharmaceuticals and Medical Devices Agency (PMDA)

  • Medicines & Healthcare products Regulatory Agency (MHRA)

    PATIENTS HELPED

    • Over 1.2 million patients reached

    • More than 11,000 patients helped

    • 100% successful deliveries to 88 countries

This content has been reviewed by a Medical Doctor.
CIBINQO (ABROCITINIB) Package

28 tablets of 50 mg, 28 tablets of 100 mg, 28 tablets of 200 mg

Reviews

There are no reviews yet.

Be the first to review “Cibinqo (abrocitinib)”

Your email address will not be published. Required fields are marked *

Shopping Cart